arrow
Return

DILANTIN DIGITAL DEFECTS

delete1981-08-01
delete17
PRE
AI
R
Robert B. Johnson
L
Lowell A. Goldsmith
DOI:10.1016/S0190-9622(81)70087-2delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Diphenylhydantoin (phenytoin) is a widely used drug with multiple adverse effects, several of them cutaneous. Prenatal exposure to hydantoins may result in a spectrum of structural, developmental and behavioral changes known as the fetal hydantoin syndrome (FHS). A patient with the dysmorphic characteristics of FHS had unusual hyperpigmentation of several fingernails, a finding which had not been described in other patients with FHS. A mechanism for the dysmorphic action of phenytoin on the developing fetus, consonant with the known effects of hydantoins on collagen metabolism was proposed.
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Journal of the American Academy of Dermatology cover
Journal of the American Academy of Dermatology
IF:
11.8
Papers:
2.6W
Citations:
3.9W

Organization

No organization information available